Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Avalo Therapeutics Inc (AVTX)

Healthcare Biotechnology
18.30 $
-5.9% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Avalo Therapeutics Inc (AVTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 76.6% of the shares are freely tradable; institutional investors hold 76.6%.

Ownership Structure

Institutional ownership
76.6%
Insiders
1.7%
Float
76.6%
Short % of float
14.1%
Shares Outstanding
53Mio.

Largest Shareholders

Institutions

Institutions AVTX
Name Stake (%) Shares Change (%) Date
FMR Inc 5.48 2,879,481 +1,207.1 03/31/2026
T. Rowe Price Investment Management,Inc. 4.11 2,162,684 +0.0 03/31/2026
Caligan Partners LP 3.11 1,635,023 +85.5 03/31/2026
Bvf Inc 3.11 1,632,845 +20.5 03/31/2026
venBio Select Advisor LLC 2.68 1,410,000 +0.0 03/31/2026
Affinity Asset Advisors, LLC 2.55 1,340,840 +27.6 03/31/2026

Funds

Funds AVTX
Name Stake (%) Shares Change (%) Date
Fidelity Stock Selector Small Cap 2.84 758,500 +360.5 03/31/2026
T. Rowe Price US Small-Cap Core Equity 2.54 678,823 +0.0 03/31/2026
T. Rowe Price Small-Cap Stock 2.54 678,340 -0.1 04/30/2026
FIAM Small Cap Core CIT Cl B 2.51 670,700 +28.5 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
27. Jul 2026 Doyle Mittie Chief Medical Officer Sell 1,000 20.00 20,000
27. Jul 2026 Doyle Mittie Chief Medical Officer Other 1,000 12.65 12,650

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?